Macrophage migration inhibitory factor and autism spectrum disorders

Area of Science:

• Neurodevelopmental Disorders
• Immunology
• Genetics

Background:

• Autism spectrum disorders (ASD) are childhood neurodevelopmental disorders marked by social, communicative, and behavioral challenges.
• Macrophage migration inhibitory factor (MIF) is a key regulator of innate immunity.
• Previous studies suggest altered immune responses in ASD and link MIF to immune activation.

Purpose of the Study:

• To investigate the potential role of MIF as a candidate gene in autism spectrum disorder.
• To explore the association between MIF gene polymorphisms and ASD.
• To examine MIF plasma levels in individuals with ASD.

Main Methods:

• Genetic association study in two independent family sets from the US and Holland (totaling 1059 participants).
• Genotyping of two functional polymorphisms in the MIF gene promoter region.
• Analysis of plasma MIF concentrations in a subset of Dutch participants.

Main Results:

• Significant genetic associations were found between MIF promoter polymorphisms and ASD-related behaviors.
• Individuals with ASD exhibited elevated circulating MIF levels compared to unaffected siblings.
• Plasma MIF concentrations positively correlated with the severity of multiple ASD symptoms.

Conclusions:

• MIF is identified as a potential susceptibility gene for autism spectrum disorder.
• Further research is needed to elucidate the precise relationship between MIF and ASD behavioral components.
• Investigating the pathogenic mechanisms and clinical utility of MIF genotyping in ASD is warranted.